These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 3762803
1. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative. Bures L, Motycka K, Bostík J, Slavík K, Jirásek A. Neoplasma; 1986; 33(4):409-16. PubMed ID: 3762803 [Abstract] [Full Text] [Related]
2. The chemotherapy of C3H mice bearing Gardner lymphosarcoma with bovine fibrinogen-methotrexate derivative. Motycka K, Slavík K, Dyr JE, Balcarová A, Vodrázka Z. Neoplasma; 1981; 28(1):3-10. PubMed ID: 6895104 [Abstract] [Full Text] [Related]
3. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing. Bures L, Bostík J, Motycka K, Spundová M, Rehák L. Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341 [Abstract] [Full Text] [Related]
7. Treatment of solid Gardner lymphosarcoma with methotrexate sorbed on 2-hydroxyethylmethacrylate polymer in combination with leukovorin. Motycka K, Slavík K, Balcarbová A, Cihar R, Spacek P, Kubín M. Neoplasma; 1978; 25(2):217-25. PubMed ID: 306074 [Abstract] [Full Text] [Related]
8. Effect of free and bovine fibrinogen-bound methotrexate and dibromoaminopterin on the dissemination of solid Gardner lymphosarcoma. Motycka K, Dyr JE, Macáková A, Slavík K. Neoplasma; 1982; 29(2):197-204. PubMed ID: 6896744 [Abstract] [Full Text] [Related]
9. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. IV. Therapy of murine melanoma B16 by human serum albumin-methotrexate derivative. Bostík J, Bures L, Spundová M. Neoplasma; 1988; 35(3):343-9. PubMed ID: 3405342 [Abstract] [Full Text] [Related]
10. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan. Motycka K, Chudomel V, Bednár M, Bostík J. Arch Immunol Ther Exp (Warsz); 1984; 32(4):413-9. PubMed ID: 6549500 [Abstract] [Full Text] [Related]
12. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. V. Alternative method for preparation of serum albumin-methotrexate derivative. Bures L, Lichý A, Bostík J, Spundová M. Neoplasma; 1990; 37(3):225-31. PubMed ID: 2370913 [Abstract] [Full Text] [Related]
13. Immunogenicity of the Gardner lymphosarcoma for the mice of the strain C3H (H-2k). II. Alteration of the growth and dissemination of solid Gardner lymphosarcoma following immunization by an extract of the ascitic tumor. Motycka K, Bostík J, Bures L, Slavík K, Jirásek A. Neoplasma; 1986; 33(2):177-85. PubMed ID: 3754937 [Abstract] [Full Text] [Related]
14. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. I. Preparation of pea seed lectin-methotrexate derivative and the preliminary experiments. Slavík K, Bures L, Svihovcová P, Kronrád L. Neoplasma; 1985; 32(4):415-9. PubMed ID: 4047253 [Abstract] [Full Text] [Related]